BioSymetrics - About the company
BioSymetrics is a series A company based in New York City (United States), founded in 2015 by Anthony Iacovone. It operates as a Provider of a cognitive computing-based biomedical intelligence platform. BioSymetrics has raised $4.88M in funding. The company has 145 active competitors, including 63 funded and 8 that have exited. Its top competitors include companies like Insitro, DNAnexus and Atomwise.
Company Details
Provider of a cognitive computing-based biomedical intelligence platform. It provides pre-processing, analytics and zero-latency machine learning for cases in bioinformatics, R&D clinical informatics, target discovery, and computational biology. It also provides predictive analytics on many kinds of R&D and healthcare data.
- Website
- www.biosymetrics.com
- Email ID
- *****@BioSymetrics.com
- Phone Number
- +1 **********
Key Metrics
Founded Year
2015
Location
New York City, United States
Stage
Series A
Total Funding
$4.88M in 2 rounds
Latest Funding Round
Investors
Ranked
50th among 145 active competitors
Employee Count
12 as on Sep 30, 2026
Legal entities associated with BioSymetrics
BioSymetrics is associated with 1 legal entity given below:
Legal Entity Name | Date of Incorporation | Revenue | Latest Employee Count | Reports |
|---|---|---|---|---|
LUNFARDA LLC CIN: 6223993 , United States, Active | Jul 20, 2021 | - | - | - |
Sign up to download BioSymetrics' company profile
BioSymetrics's funding and investors
BioSymetrics has raised a total funding of $4.88M over 2 rounds. Its first funding round was on Aug 04, 2021. Its latest funding round was a Grant (prize money) round on Jul 23, 2025 for $*****. 1 investor participated in its latest round. BioSymetrics has 4 institutional investors.
Here is the list of recent funding rounds of BioSymetrics:
Date of Funding | Funding Amount | Round Name | Post-Money Valuation | Revenue Multiple | Lead Investors | Other Investors |
|---|---|---|---|---|---|---|
Jul 23, 2025 | 5872398 | Grant (prize money) | 5712756 | 9235951 | 3814800 | 9230330 |
Aug 04, 2021 | 3646109 | Series A | 7531172 | 2998024 | 6104105 | 2264476 |
View details of BioSymetrics's funding rounds and investors
BioSymetrics' founders and board of directors
Founder? Claim ProfileThe founders of BioSymetrics is Anthony Iacovone.
Here are the details of BioSymetrics' key team members:
- Anthony Iacovone: Co-Founder & CEO of BioSymetrics and founder of 2 other companies, SnapStudy.ai and AdTheorent. They serve on the board of 1 company.Contact Info: 2 email addresses
View details of BioSymetrics's Founder profiles and Board Members
BioSymetrics' employee count trend
BioSymetrics has 12 employees as of Sep 26. Here is BioSymetrics's employee count trend over the years:
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
BioSymetrics's Competitors and alternates
Top competitors of BioSymetrics include Insitro, DNAnexus and Atomwise. Here is the list of Top 10 competitors of BioSymetrics, ranked by Tracxn score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st | Insitro 2018, San Francisco (United States), Series C | Developer of machine learning platform for drug discovery and development | $643M | 70/100 | |
2nd | DNAnexus 2009, Mountain View (United States), Series H | Provider of cloud-based genome informatics & data management platform | $473M | 70/100 | |
3rd | Atomwise 2012, San Francisco (United States), Series B | Developer of artificial intelligence platform for small molecule drug discovery | $219M | 67/100 | |
4th | Antiverse 2017, Cardiff (United Kingdom), Series A | Developer of computational platform for de novo design of antibody therapeutics | $20M | 67/100 | |
5th | Immunai Technologies 2018, United States, Series B | Developer of next-generation of immunomodulatory therapeutics | $295M | 65/100 | |
6th | Asimov 2017, Boston (United States), Series B | Provider of integrated suite for advanced genetic design and manufacturing | $234M | 65/100 | |
7th | Cytel 1987, Cambridge (United States), Acquired | Provider of data analysis and statistical solutions for the life sciences industry | $2M | 65/100 | |
8th | Metagenomi 2016, Berkeley (United States), Public | Digital gene editing technologies for drug development | $376M | 64/100 | |
9th | Relation 2019, London (United Kingdom), Seed | AI-based drug development tools for researchers | $116M | 64/100 | |
10th | Somite 2023, Boston (United States), Series A | AI-driven platform to produce human tissue for cell-based therapies | $60M | 63/100 | |
50th | BioSymetrics 2015, New York City (United States), Series A | Provider of a cognitive computing-based biomedical intelligence platform | $4.88M | 39/100 |
Looking for more details on BioSymetrics's competitors? Click here to see the top ones
BioSymetrics's Investments and acquisitions
BioSymetrics has made no investments or acquisitions yet.
Reports related to BioSymetrics
Here is the latest report on BioSymetrics's sector:
News related to BioSymetrics
•
BioSymetrics and Brigham and Women’s Hospital Awarded NIH Grant to Develop AI Platform for Alcohol Use DisorderNewswire•Sep 11, 2025•BioSymetrics
•
Lunai Bioworks Inc. Unveils Transformer Platform to Secure Generative AI and Accelerate Drug DiscoveryNewswire•Sep 09, 2025•BioSymetrics
•
Renovaro Launches AI-Based Neurotoxin Countermeasure Initiative Addressing National Security NeedsNewswire•Jun 30, 2025•BioSymetrics, Renovaro
•
•
Deerfield Management and BioSymetrics partner to discover and develop novel therapeuticsPR Newswire•Oct 31, 2022•Deerfield, BioSymetrics
•
Sema4 and BioSymetrics Partner on Data-Driven Drug Discovery to Advance Precision MedicineGlobeNewswire•Feb 22, 2022•Sema4, BioSymetrics
•
BioSymetrics Collaborates with Janssen and Sema4 to Predict the Onset of COVID-19PR Newswire•Aug 19, 2020•BioSymetrics, Sema4, Janssen Pharmaceutica
•
BioSymetrics Launches New AI Capability to Improve Patient OutcomesHIT Consultant•Oct 29, 2019•BioSymetrics
•
•
Are you a Founder ?
FAQs about BioSymetrics
Explore our recently published companies
- Benzy Infotech Data Center - India based, 2006 founded, Unfunded company
- CREATE Commercial Mortgage - Edmonton based, 2020 founded, Unfunded company
- Kaytek - Barakaldo based, 2018 founded, Unfunded company
- Guenther Heisskanaltechnik - Germany based, Unfunded company
- LINDIS - Spain based, 1994 founded, Unfunded company
- Netport - India based, 2026 founded, Unfunded company
